PERFORMANCE. ENDURANCE. STRENGTH. POWERED BY Exclusively available through
TODAY S SPORTS NUTRITION CHALLENGE: Innovation in the Creatine Category
HORN S SCIENCE-BASED SOLUTION: Greater Creatine Absorption POWERED BY Exclusively available through
Creatine Backgrounder Creatine is the most well-studied dietary supplement for exercise performance (arguably for any application) on the planet. By far has the greatest benefit/risk ratio with a great safety profile Naturally occurring in meats, fish, poultry, etc. Important role in energy metabolism, cellular resilience to hypoxic and energy-depleted conditions. Synthesized in liver, kidney and pancreas and stored mainly in skeletal muscles, heart and brain.
Creatine Backgrounder
Creatine Backgrounder Muscle Total Creatine Stores 180 140 155 mmol/kgdw 160 140 120 100 80 60 100 120 40 20 0 Vegetarian Normal Creatine Loading Creating Loading with CHO or CHO/PRO
Creatine Backgrounder Bigger, Faster, Stronger and More Work Capacity
Creatine Backgrounder
Creatine Backgrounder
Outlast Isomaltulose Enhanced Creatine Patented combination (composition, not just methods utility patent) of isomaltulose (Palatinose ) and creatine. Includes ANY source of isomaltulose and ANY source or version of creatine. RATIONALE: the use of isomultulose vs. other sugars allows for the efficient use of glucose to drive other bioactive ingredients such as creatine, amino acids, etc., through transport proteins within the gut. RESULT: enhanced systemic bioavailability and uptake. Clinically studied and presented conference at International Society Sports Nutrition. Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
How Does Outlast Work? Modulated kinetics of enzymatic action on isomaltulose Allows for sustained interaction of glucose molecules with the energydependent creatine/ amino acid transporters Increased efficiency of uptake/ utilization from co-ingested creatine with Outlast Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Outlast Human Clinical Study DESIGN RDBCT with N=30 males Randomized to 3g of creatine monohydrate in combination with either isomaltulose (Palatinose ) or dextrose in the following doses: 5g, 17g or 50g. Rate of absorption (T Max ), total absorption (AUC 0-8h and C Max ) determined from blood RESULTS C Max was ~50.8% higher for the Palatinose treatment with the 17g dose (p<0.001) vs. dextrose; AUC was ~35.4% greater with Palatinose vs. dextrose at 50g dose (p=0.046) For all three doses (cumulatively) C max and AUC were significantly greater for Palatinose vs. dextrose by 32% and 30.9%, respectively (p=0.005 and 0.027). Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Highlight of Outlast Clinical Study Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Outlast Clinical Study Conclusion Creatine appears to be absorbed more efficiently when combined with isomaltulose over dextrose supported by a significantly higher C Max for the 17g concentration and a significantly higher AUC for the 50g concentration. The 17g and 50g formulations appear to be superior to the 5g concentration. Isomaltulose appears to be a beneficial carbohydrate for facilitating the delivery of creatine to the body. Isomaltulose also has metabolic side-benefits. Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Outlast Dose Range 3:7 (3g creatine monohydrate + 7g Palatinose ) This has creatine claims. 3:17 (3g creatine monohydrate + 17g Palatinose ) This combination is the strongest scientific substantiation for Outlast claims. Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Outlast Potential Applications Pre- and intra-workout products Meal replacement powders for quality, lean muscle mass Endurance performance products Strength/power performance products Gains in muscle mass Products for cognitive performance under duress Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Outlast Potential Claims Provides greater peak and sustained concentrations of creatine in blood* Facilitate creatine uptake and systemic bioavailability Extends energy supply* Increases muscle mass and strength adaptations during training* Increases work capacity & training tolerance; single & repetitive sprint performance* Increases anaerobic threshold and aerobic capacity* Improves recovery* Outlast is a proprietary and patented innovation exclusively available through HORN. Palatinose is a registered trademark of BENEO GmbH. The term Palatinose may not be reproduced by any means or in any form whatsoever without written permission. *These statements have not been evaluated by Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
PERFORMANCE. ENDURANCE. STRENGTH. REQUEST A SAMPLE TODAY. Exclusively available through